TLR7 and psoriasis: Due to limited treatment options and the need of new therapies treating the underlying causes of Ps, this disease is a major focus of research and development by the pharmaceutical industry; Biopta is involved in the project entitled “Toll-like receptor 7 (TLR7) small molecules in the treatment of cancer and inflammatory disease—Psoriasis”.